Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Video Abstracts
  • Reviews
    • View all reviews ...
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • Clonal Hematopoiesis (Oct 2024)
    • Sex Differences in Medicine (Sep 2024)
    • Vascular Malformations (Apr 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Video Abstracts
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
Top
  • View PDF
  • Download citation information
  • Send a comment
  • Terms of use
  • Standard abbreviations
  • Need help? Email the journal
  • Top
  • Abstract
  • Introduction
  • Methods
  • Results
  • Discussion
  • Acknowledgments
  • References
  • Version history
  • Article usage
  • Citations to this article

Advertisement

Article Free access | 10.1172/JCI11869

Molecular basis of ocular abnormalities associated with proximal renal tubular acidosis

Tomohiko Usui,1 Masumi Hara,2 Hiroaki Satoh,2 Nobuo Moriyama,3 Humie Kagaya,1 Shiro Amano,1 Tetsuro Oshika,1 Yasuo Ishii,4 Nobuhiro Ibaraki,5 Chiaki Hara,2 Motoei Kunimi,2 Eisei Noiri,2 Kazuhisa Tsukamoto,2 Jun Inatomi,6 Hayato Kawakami,7 Hitoshi Endou,6 Takashi Igarashi,8 Astuo Goto,2 Toshiro Fujita,2 Makoto Araie,1 and George Seki2

1Department of Ophthalmology,2Department of Internal Medicine, and3Department of Hemodialysis and Apheresis, Faculty of Medicine, Tokyo University, Bunkyo-ku, Tokyo, Japan4New Vision Eye Institute, Taito-ku, Tokyo, Japan5Department of Ophthalmology, Nihon Medical University, Bunkyo-ku, Tokyo, Japan6Department of Pharmacology and Toxicology, and7Department of Anatomy, Kyorin University School of Medicine, Mitaka, Tokyo, Japan8Department of Pediatrics, Faculty of Medicine, Tokyo University, Bunkyo-ku, Tokyo, Japan

Address correspondence to: George Seki, Department of Internal Medicine, Faculty of Medicine, Tokyo University, 7-3-1 Hongo, Bunkyo-ku, Tokyo 113-0033, Japan. Phone: 81-3-3815-5411 ext. 33004; Fax: 81-3-5800-8806; E-mail: georgeseki-tky@umin.ac.jp.

Find articles by Usui, T. in: PubMed | Google Scholar

1Department of Ophthalmology,2Department of Internal Medicine, and3Department of Hemodialysis and Apheresis, Faculty of Medicine, Tokyo University, Bunkyo-ku, Tokyo, Japan4New Vision Eye Institute, Taito-ku, Tokyo, Japan5Department of Ophthalmology, Nihon Medical University, Bunkyo-ku, Tokyo, Japan6Department of Pharmacology and Toxicology, and7Department of Anatomy, Kyorin University School of Medicine, Mitaka, Tokyo, Japan8Department of Pediatrics, Faculty of Medicine, Tokyo University, Bunkyo-ku, Tokyo, Japan

Address correspondence to: George Seki, Department of Internal Medicine, Faculty of Medicine, Tokyo University, 7-3-1 Hongo, Bunkyo-ku, Tokyo 113-0033, Japan. Phone: 81-3-3815-5411 ext. 33004; Fax: 81-3-5800-8806; E-mail: georgeseki-tky@umin.ac.jp.

Find articles by Hara, M. in: PubMed | Google Scholar

1Department of Ophthalmology,2Department of Internal Medicine, and3Department of Hemodialysis and Apheresis, Faculty of Medicine, Tokyo University, Bunkyo-ku, Tokyo, Japan4New Vision Eye Institute, Taito-ku, Tokyo, Japan5Department of Ophthalmology, Nihon Medical University, Bunkyo-ku, Tokyo, Japan6Department of Pharmacology and Toxicology, and7Department of Anatomy, Kyorin University School of Medicine, Mitaka, Tokyo, Japan8Department of Pediatrics, Faculty of Medicine, Tokyo University, Bunkyo-ku, Tokyo, Japan

Address correspondence to: George Seki, Department of Internal Medicine, Faculty of Medicine, Tokyo University, 7-3-1 Hongo, Bunkyo-ku, Tokyo 113-0033, Japan. Phone: 81-3-3815-5411 ext. 33004; Fax: 81-3-5800-8806; E-mail: georgeseki-tky@umin.ac.jp.

Find articles by Satoh, H. in: PubMed | Google Scholar

1Department of Ophthalmology,2Department of Internal Medicine, and3Department of Hemodialysis and Apheresis, Faculty of Medicine, Tokyo University, Bunkyo-ku, Tokyo, Japan4New Vision Eye Institute, Taito-ku, Tokyo, Japan5Department of Ophthalmology, Nihon Medical University, Bunkyo-ku, Tokyo, Japan6Department of Pharmacology and Toxicology, and7Department of Anatomy, Kyorin University School of Medicine, Mitaka, Tokyo, Japan8Department of Pediatrics, Faculty of Medicine, Tokyo University, Bunkyo-ku, Tokyo, Japan

Address correspondence to: George Seki, Department of Internal Medicine, Faculty of Medicine, Tokyo University, 7-3-1 Hongo, Bunkyo-ku, Tokyo 113-0033, Japan. Phone: 81-3-3815-5411 ext. 33004; Fax: 81-3-5800-8806; E-mail: georgeseki-tky@umin.ac.jp.

Find articles by Moriyama, N. in: PubMed | Google Scholar

1Department of Ophthalmology,2Department of Internal Medicine, and3Department of Hemodialysis and Apheresis, Faculty of Medicine, Tokyo University, Bunkyo-ku, Tokyo, Japan4New Vision Eye Institute, Taito-ku, Tokyo, Japan5Department of Ophthalmology, Nihon Medical University, Bunkyo-ku, Tokyo, Japan6Department of Pharmacology and Toxicology, and7Department of Anatomy, Kyorin University School of Medicine, Mitaka, Tokyo, Japan8Department of Pediatrics, Faculty of Medicine, Tokyo University, Bunkyo-ku, Tokyo, Japan

Address correspondence to: George Seki, Department of Internal Medicine, Faculty of Medicine, Tokyo University, 7-3-1 Hongo, Bunkyo-ku, Tokyo 113-0033, Japan. Phone: 81-3-3815-5411 ext. 33004; Fax: 81-3-5800-8806; E-mail: georgeseki-tky@umin.ac.jp.

Find articles by Kagaya, H. in: PubMed | Google Scholar

1Department of Ophthalmology,2Department of Internal Medicine, and3Department of Hemodialysis and Apheresis, Faculty of Medicine, Tokyo University, Bunkyo-ku, Tokyo, Japan4New Vision Eye Institute, Taito-ku, Tokyo, Japan5Department of Ophthalmology, Nihon Medical University, Bunkyo-ku, Tokyo, Japan6Department of Pharmacology and Toxicology, and7Department of Anatomy, Kyorin University School of Medicine, Mitaka, Tokyo, Japan8Department of Pediatrics, Faculty of Medicine, Tokyo University, Bunkyo-ku, Tokyo, Japan

Address correspondence to: George Seki, Department of Internal Medicine, Faculty of Medicine, Tokyo University, 7-3-1 Hongo, Bunkyo-ku, Tokyo 113-0033, Japan. Phone: 81-3-3815-5411 ext. 33004; Fax: 81-3-5800-8806; E-mail: georgeseki-tky@umin.ac.jp.

Find articles by Amano, S. in: PubMed | Google Scholar

1Department of Ophthalmology,2Department of Internal Medicine, and3Department of Hemodialysis and Apheresis, Faculty of Medicine, Tokyo University, Bunkyo-ku, Tokyo, Japan4New Vision Eye Institute, Taito-ku, Tokyo, Japan5Department of Ophthalmology, Nihon Medical University, Bunkyo-ku, Tokyo, Japan6Department of Pharmacology and Toxicology, and7Department of Anatomy, Kyorin University School of Medicine, Mitaka, Tokyo, Japan8Department of Pediatrics, Faculty of Medicine, Tokyo University, Bunkyo-ku, Tokyo, Japan

Address correspondence to: George Seki, Department of Internal Medicine, Faculty of Medicine, Tokyo University, 7-3-1 Hongo, Bunkyo-ku, Tokyo 113-0033, Japan. Phone: 81-3-3815-5411 ext. 33004; Fax: 81-3-5800-8806; E-mail: georgeseki-tky@umin.ac.jp.

Find articles by Oshika, T. in: PubMed | Google Scholar

1Department of Ophthalmology,2Department of Internal Medicine, and3Department of Hemodialysis and Apheresis, Faculty of Medicine, Tokyo University, Bunkyo-ku, Tokyo, Japan4New Vision Eye Institute, Taito-ku, Tokyo, Japan5Department of Ophthalmology, Nihon Medical University, Bunkyo-ku, Tokyo, Japan6Department of Pharmacology and Toxicology, and7Department of Anatomy, Kyorin University School of Medicine, Mitaka, Tokyo, Japan8Department of Pediatrics, Faculty of Medicine, Tokyo University, Bunkyo-ku, Tokyo, Japan

Address correspondence to: George Seki, Department of Internal Medicine, Faculty of Medicine, Tokyo University, 7-3-1 Hongo, Bunkyo-ku, Tokyo 113-0033, Japan. Phone: 81-3-3815-5411 ext. 33004; Fax: 81-3-5800-8806; E-mail: georgeseki-tky@umin.ac.jp.

Find articles by Ishii, Y. in: PubMed | Google Scholar

1Department of Ophthalmology,2Department of Internal Medicine, and3Department of Hemodialysis and Apheresis, Faculty of Medicine, Tokyo University, Bunkyo-ku, Tokyo, Japan4New Vision Eye Institute, Taito-ku, Tokyo, Japan5Department of Ophthalmology, Nihon Medical University, Bunkyo-ku, Tokyo, Japan6Department of Pharmacology and Toxicology, and7Department of Anatomy, Kyorin University School of Medicine, Mitaka, Tokyo, Japan8Department of Pediatrics, Faculty of Medicine, Tokyo University, Bunkyo-ku, Tokyo, Japan

Address correspondence to: George Seki, Department of Internal Medicine, Faculty of Medicine, Tokyo University, 7-3-1 Hongo, Bunkyo-ku, Tokyo 113-0033, Japan. Phone: 81-3-3815-5411 ext. 33004; Fax: 81-3-5800-8806; E-mail: georgeseki-tky@umin.ac.jp.

Find articles by Ibaraki, N. in: PubMed | Google Scholar

1Department of Ophthalmology,2Department of Internal Medicine, and3Department of Hemodialysis and Apheresis, Faculty of Medicine, Tokyo University, Bunkyo-ku, Tokyo, Japan4New Vision Eye Institute, Taito-ku, Tokyo, Japan5Department of Ophthalmology, Nihon Medical University, Bunkyo-ku, Tokyo, Japan6Department of Pharmacology and Toxicology, and7Department of Anatomy, Kyorin University School of Medicine, Mitaka, Tokyo, Japan8Department of Pediatrics, Faculty of Medicine, Tokyo University, Bunkyo-ku, Tokyo, Japan

Address correspondence to: George Seki, Department of Internal Medicine, Faculty of Medicine, Tokyo University, 7-3-1 Hongo, Bunkyo-ku, Tokyo 113-0033, Japan. Phone: 81-3-3815-5411 ext. 33004; Fax: 81-3-5800-8806; E-mail: georgeseki-tky@umin.ac.jp.

Find articles by Hara, C. in: PubMed | Google Scholar

1Department of Ophthalmology,2Department of Internal Medicine, and3Department of Hemodialysis and Apheresis, Faculty of Medicine, Tokyo University, Bunkyo-ku, Tokyo, Japan4New Vision Eye Institute, Taito-ku, Tokyo, Japan5Department of Ophthalmology, Nihon Medical University, Bunkyo-ku, Tokyo, Japan6Department of Pharmacology and Toxicology, and7Department of Anatomy, Kyorin University School of Medicine, Mitaka, Tokyo, Japan8Department of Pediatrics, Faculty of Medicine, Tokyo University, Bunkyo-ku, Tokyo, Japan

Address correspondence to: George Seki, Department of Internal Medicine, Faculty of Medicine, Tokyo University, 7-3-1 Hongo, Bunkyo-ku, Tokyo 113-0033, Japan. Phone: 81-3-3815-5411 ext. 33004; Fax: 81-3-5800-8806; E-mail: georgeseki-tky@umin.ac.jp.

Find articles by Kunimi, M. in: PubMed | Google Scholar

1Department of Ophthalmology,2Department of Internal Medicine, and3Department of Hemodialysis and Apheresis, Faculty of Medicine, Tokyo University, Bunkyo-ku, Tokyo, Japan4New Vision Eye Institute, Taito-ku, Tokyo, Japan5Department of Ophthalmology, Nihon Medical University, Bunkyo-ku, Tokyo, Japan6Department of Pharmacology and Toxicology, and7Department of Anatomy, Kyorin University School of Medicine, Mitaka, Tokyo, Japan8Department of Pediatrics, Faculty of Medicine, Tokyo University, Bunkyo-ku, Tokyo, Japan

Address correspondence to: George Seki, Department of Internal Medicine, Faculty of Medicine, Tokyo University, 7-3-1 Hongo, Bunkyo-ku, Tokyo 113-0033, Japan. Phone: 81-3-3815-5411 ext. 33004; Fax: 81-3-5800-8806; E-mail: georgeseki-tky@umin.ac.jp.

Find articles by Noiri, E. in: PubMed | Google Scholar

1Department of Ophthalmology,2Department of Internal Medicine, and3Department of Hemodialysis and Apheresis, Faculty of Medicine, Tokyo University, Bunkyo-ku, Tokyo, Japan4New Vision Eye Institute, Taito-ku, Tokyo, Japan5Department of Ophthalmology, Nihon Medical University, Bunkyo-ku, Tokyo, Japan6Department of Pharmacology and Toxicology, and7Department of Anatomy, Kyorin University School of Medicine, Mitaka, Tokyo, Japan8Department of Pediatrics, Faculty of Medicine, Tokyo University, Bunkyo-ku, Tokyo, Japan

Address correspondence to: George Seki, Department of Internal Medicine, Faculty of Medicine, Tokyo University, 7-3-1 Hongo, Bunkyo-ku, Tokyo 113-0033, Japan. Phone: 81-3-3815-5411 ext. 33004; Fax: 81-3-5800-8806; E-mail: georgeseki-tky@umin.ac.jp.

Find articles by Tsukamoto, K. in: PubMed | Google Scholar

1Department of Ophthalmology,2Department of Internal Medicine, and3Department of Hemodialysis and Apheresis, Faculty of Medicine, Tokyo University, Bunkyo-ku, Tokyo, Japan4New Vision Eye Institute, Taito-ku, Tokyo, Japan5Department of Ophthalmology, Nihon Medical University, Bunkyo-ku, Tokyo, Japan6Department of Pharmacology and Toxicology, and7Department of Anatomy, Kyorin University School of Medicine, Mitaka, Tokyo, Japan8Department of Pediatrics, Faculty of Medicine, Tokyo University, Bunkyo-ku, Tokyo, Japan

Address correspondence to: George Seki, Department of Internal Medicine, Faculty of Medicine, Tokyo University, 7-3-1 Hongo, Bunkyo-ku, Tokyo 113-0033, Japan. Phone: 81-3-3815-5411 ext. 33004; Fax: 81-3-5800-8806; E-mail: georgeseki-tky@umin.ac.jp.

Find articles by Inatomi, J. in: PubMed | Google Scholar

1Department of Ophthalmology,2Department of Internal Medicine, and3Department of Hemodialysis and Apheresis, Faculty of Medicine, Tokyo University, Bunkyo-ku, Tokyo, Japan4New Vision Eye Institute, Taito-ku, Tokyo, Japan5Department of Ophthalmology, Nihon Medical University, Bunkyo-ku, Tokyo, Japan6Department of Pharmacology and Toxicology, and7Department of Anatomy, Kyorin University School of Medicine, Mitaka, Tokyo, Japan8Department of Pediatrics, Faculty of Medicine, Tokyo University, Bunkyo-ku, Tokyo, Japan

Address correspondence to: George Seki, Department of Internal Medicine, Faculty of Medicine, Tokyo University, 7-3-1 Hongo, Bunkyo-ku, Tokyo 113-0033, Japan. Phone: 81-3-3815-5411 ext. 33004; Fax: 81-3-5800-8806; E-mail: georgeseki-tky@umin.ac.jp.

Find articles by Kawakami, H. in: PubMed | Google Scholar

1Department of Ophthalmology,2Department of Internal Medicine, and3Department of Hemodialysis and Apheresis, Faculty of Medicine, Tokyo University, Bunkyo-ku, Tokyo, Japan4New Vision Eye Institute, Taito-ku, Tokyo, Japan5Department of Ophthalmology, Nihon Medical University, Bunkyo-ku, Tokyo, Japan6Department of Pharmacology and Toxicology, and7Department of Anatomy, Kyorin University School of Medicine, Mitaka, Tokyo, Japan8Department of Pediatrics, Faculty of Medicine, Tokyo University, Bunkyo-ku, Tokyo, Japan

Address correspondence to: George Seki, Department of Internal Medicine, Faculty of Medicine, Tokyo University, 7-3-1 Hongo, Bunkyo-ku, Tokyo 113-0033, Japan. Phone: 81-3-3815-5411 ext. 33004; Fax: 81-3-5800-8806; E-mail: georgeseki-tky@umin.ac.jp.

Find articles by Endou, H. in: PubMed | Google Scholar

1Department of Ophthalmology,2Department of Internal Medicine, and3Department of Hemodialysis and Apheresis, Faculty of Medicine, Tokyo University, Bunkyo-ku, Tokyo, Japan4New Vision Eye Institute, Taito-ku, Tokyo, Japan5Department of Ophthalmology, Nihon Medical University, Bunkyo-ku, Tokyo, Japan6Department of Pharmacology and Toxicology, and7Department of Anatomy, Kyorin University School of Medicine, Mitaka, Tokyo, Japan8Department of Pediatrics, Faculty of Medicine, Tokyo University, Bunkyo-ku, Tokyo, Japan

Address correspondence to: George Seki, Department of Internal Medicine, Faculty of Medicine, Tokyo University, 7-3-1 Hongo, Bunkyo-ku, Tokyo 113-0033, Japan. Phone: 81-3-3815-5411 ext. 33004; Fax: 81-3-5800-8806; E-mail: georgeseki-tky@umin.ac.jp.

Find articles by Igarashi, T. in: PubMed | Google Scholar

1Department of Ophthalmology,2Department of Internal Medicine, and3Department of Hemodialysis and Apheresis, Faculty of Medicine, Tokyo University, Bunkyo-ku, Tokyo, Japan4New Vision Eye Institute, Taito-ku, Tokyo, Japan5Department of Ophthalmology, Nihon Medical University, Bunkyo-ku, Tokyo, Japan6Department of Pharmacology and Toxicology, and7Department of Anatomy, Kyorin University School of Medicine, Mitaka, Tokyo, Japan8Department of Pediatrics, Faculty of Medicine, Tokyo University, Bunkyo-ku, Tokyo, Japan

Address correspondence to: George Seki, Department of Internal Medicine, Faculty of Medicine, Tokyo University, 7-3-1 Hongo, Bunkyo-ku, Tokyo 113-0033, Japan. Phone: 81-3-3815-5411 ext. 33004; Fax: 81-3-5800-8806; E-mail: georgeseki-tky@umin.ac.jp.

Find articles by Goto, A. in: PubMed | Google Scholar

1Department of Ophthalmology,2Department of Internal Medicine, and3Department of Hemodialysis and Apheresis, Faculty of Medicine, Tokyo University, Bunkyo-ku, Tokyo, Japan4New Vision Eye Institute, Taito-ku, Tokyo, Japan5Department of Ophthalmology, Nihon Medical University, Bunkyo-ku, Tokyo, Japan6Department of Pharmacology and Toxicology, and7Department of Anatomy, Kyorin University School of Medicine, Mitaka, Tokyo, Japan8Department of Pediatrics, Faculty of Medicine, Tokyo University, Bunkyo-ku, Tokyo, Japan

Address correspondence to: George Seki, Department of Internal Medicine, Faculty of Medicine, Tokyo University, 7-3-1 Hongo, Bunkyo-ku, Tokyo 113-0033, Japan. Phone: 81-3-3815-5411 ext. 33004; Fax: 81-3-5800-8806; E-mail: georgeseki-tky@umin.ac.jp.

Find articles by Fujita, T. in: PubMed | Google Scholar

1Department of Ophthalmology,2Department of Internal Medicine, and3Department of Hemodialysis and Apheresis, Faculty of Medicine, Tokyo University, Bunkyo-ku, Tokyo, Japan4New Vision Eye Institute, Taito-ku, Tokyo, Japan5Department of Ophthalmology, Nihon Medical University, Bunkyo-ku, Tokyo, Japan6Department of Pharmacology and Toxicology, and7Department of Anatomy, Kyorin University School of Medicine, Mitaka, Tokyo, Japan8Department of Pediatrics, Faculty of Medicine, Tokyo University, Bunkyo-ku, Tokyo, Japan

Address correspondence to: George Seki, Department of Internal Medicine, Faculty of Medicine, Tokyo University, 7-3-1 Hongo, Bunkyo-ku, Tokyo 113-0033, Japan. Phone: 81-3-3815-5411 ext. 33004; Fax: 81-3-5800-8806; E-mail: georgeseki-tky@umin.ac.jp.

Find articles by Araie, M. in: PubMed | Google Scholar

1Department of Ophthalmology,2Department of Internal Medicine, and3Department of Hemodialysis and Apheresis, Faculty of Medicine, Tokyo University, Bunkyo-ku, Tokyo, Japan4New Vision Eye Institute, Taito-ku, Tokyo, Japan5Department of Ophthalmology, Nihon Medical University, Bunkyo-ku, Tokyo, Japan6Department of Pharmacology and Toxicology, and7Department of Anatomy, Kyorin University School of Medicine, Mitaka, Tokyo, Japan8Department of Pediatrics, Faculty of Medicine, Tokyo University, Bunkyo-ku, Tokyo, Japan

Address correspondence to: George Seki, Department of Internal Medicine, Faculty of Medicine, Tokyo University, 7-3-1 Hongo, Bunkyo-ku, Tokyo 113-0033, Japan. Phone: 81-3-3815-5411 ext. 33004; Fax: 81-3-5800-8806; E-mail: georgeseki-tky@umin.ac.jp.

Find articles by Seki, G. in: PubMed | Google Scholar

Published July 1, 2001 - More info

Published in Volume 108, Issue 1 on July 1, 2001
J Clin Invest. 2001;108(1):107–115. https://doi.org/10.1172/JCI11869.
© 2001 The American Society for Clinical Investigation
Published July 1, 2001 - Version history
Received: January 29, 2001; Accepted: May 14, 2001
View PDF
Abstract

Proximal renal tubular acidosis associated with ocular abnormalities such as band keratopathy, glaucoma, and cataracts is caused by mutations in the Na+-HCO3– cotransporter (NBC-1). However, the mechanism by which NBC-1 inactivation leads to such ocular abnormalities remains to be elucidated. By immunological analysis of human and rat eyes, we demonstrate that both kidney type (kNBC-1) and pancreatic type (pNBC-1) transporters are present in the corneal endothelium, trabecular meshwork, ciliary epithelium, and lens epithelium. In the human lens epithelial (HLE) cells, RT-PCR detected mRNAs of both kNBC-1 and pNBC-1. Although a Na+-HCO3– cotransport activity has not been detected in mammalian lens epithelia, cell pH (pHi) measurements revealed the presence of Cl–-independent, electrogenic Na+-HCO3– cotransport activity in HLE cells. In addition, up to 80% of amiloride-insensitive pHi recovery from acid load in the presence of HCO3–/CO2 was inhibited by adenovirus-mediated transfer of a specific hammerhead ribozyme against NBC-1, consistent with a major role of NBC-1 in overall HCO3– transport by the lens epithelium. These results indicate that the normal transport activity of NBC-1 is indispensable not only for the maintenance of corneal and lenticular transparency but also for the regulation of aqueous humor outflow.

Introduction

The persistent form of isolated proximal renal tubular acidosis (pRTA) is rare, but frequently associated with ocular abnormalities such as band keratopathy, glaucoma, and cataracts (1–4). We have shown recently that inactivating mutations in the Na+-HCO3– cotransporter (NBC-1) cause this disorder (4). NBC-1, originally cloned from amphibian kidney (5), has at least three isoforms: kNBC-1 from the kidney, pNBC-1 from the pancreas, and hNBC-1 from the heart. While the patterns of tissue distribution are quite different among these isoforms, pNBC-1 differs from kNBC-1 only at the N terminus. In addition, hNBC-1 is identical to pNBC-1 at the amino acid level and differs only in its 5′-untranslated region (6–9). These NBC-1 isoforms originate from the common SLC4A4 gene by alternative splicing (9). It is therefore possible that mutations in the common NBC-1 region may affect the properties of all these isoforms, resulting in renal and extrarenal manifestations. For example, because kNBC-1 is thought to be responsible for a majority of HCO3– reabsorption from renal proximal tubules (10–12), its inactivation can readily explain the occurrence of pRTA. Recent studies (13, 14) suggest that NBC-1 may also play a significant role in HCO3– transport by the corneal endothelium, which potentially could explain the occurrence of band keratopathy (4). However, the mechanism by which NBC-1 inactivation leads to glaucoma and cataracts is completely unknown. Moreover, the exact localization of NBC-1 in the whole eye has not been determined. Elucidation of the roles of NBC-1 in the eye would be extremely important, since the underlying molecular mechanisms of glaucoma and cataracts, the leading causes of blindness in the world (15, 16), are not fully understood. In the present study we performed immunological analysis on human and rat eyes using an affinity-purified Ab that recognizes both kNBC-1 and pNBC-1 (17). To discriminate between these two isoforms of NBC-1, we also raised Ab’s against their N terminal–specific regions. Our results showed that NBC-1 is present in the corneal endothelium, trabecular meshwork, ciliary epithelium, and lens epithelium. In addition, we revealed that NBC-1 plays a major role in HCO3– transport by the human lens epithelial (HLE) cells. From these observations we propose that the inactivation of NBC-1 directly disrupts the homeostasis of cornea, trabecular meshwork, and lens, resulting in band keratopathy, glaucoma, and cataracts.

Methods

Immunohistochemistry. In addition to the Ab against the C-terminal region of NBC-1 (17), two antipeptide Ab’s were raised against the isoform-specific regions of NBC-1. Synthetic peptides corresponding to the N-terminal regions of human kNBC-1 (amino acids 4–16) or human pNBC-1 (amino acids 2–12) were coupled to C-terminal cysteine, conjugated to keyhole limpet hemocyanin, and affinity-purified Ab’s were raised in rabbits as described (17).

Human eyes were obtained from Rocky Mountain Lions Eye Bank (Aurora, Colorado, USA), and rat eyes were enucleated. Specimens were prefixed with 4% paraformaldehyde in 100 mmol/l PBS, then embedded into Tissue-Tek OCT (Miles Inc., Elkhart, Illinois, USA), quickly frozen in liquid nitrogen, and stored at –80°C until experiments were performed. For immunoperoxidase detection, frozen eyes were cut into 5-μm thickness. After treatment with goat serum, the sections were incubated with the diluted (1:100) anti–NBC-1 Ab’s (common type, anti–kNBC-1, and anti–pNBC-1). The absorption tests were performed in the presence of the corresponding antigen peptides (10 mg/l). Immunoreactivities were detected by a Histofine SAB-PO Kit (Nichirei Corp., Tokyo, Japan). In brief, the sections were incubated with biotinylated anti-rabbit goat serum, then incubated with streptavidin-biotin-peroxidase. The final reaction product was visualized with 3, 3′-diaminobenzidine tetrahydrochloride. For immunofluorescence detection, the prefixed tissues were permeated by sequential incubation in PBS containing 10%, 20%, and 30% sucrose, embedded into Tissue-Tek OCT, and snap-frozen in liquid nitrogen. Sections 10-μm thick were prepared, air dried, and immersed in PBS, and treated with 5% normal donkey serum (Jackson ImmunoResearch Laboratories Inc., West Grove, Pennsylvania, USA), followed by incubation in the diluted (1:100) anti–NBC-1 Ab’s. The sections were then incubated with 3.75 mg/l Cy3-conjugated Affipure donkey anti-rabbit IgG (H+L; Jackson ImmunoResearch Laboratories Inc.) with SYBR green I nucleic acid gel stain (1:50,000 dilution of the stock reagent; Molecular Probes Inc., Eugene, Oregon, USA), and observed with a confocal laser-scanning microscope (MRC-1024K; Japan Bio-Rad Laboratories, Tokyo, Japan).

Cell culture. Immortalized HLE cells (18) were cultured in DMEM (Life Technologies Inc., Grand Island, New York, USA) containing 20% FBS and 20 mg/l gentamycin. They were trypsinized by 0.05% trypsin/EDTA solution and subcultured onto 6-mm round glass coverslips to be used for the intracellular pH (pHi) measurements.

RT-PCR. RT-PCR was performed using the cDNA template derived from mRNA of HLE cells as described previously (17). The conditions for PCR were as follows: 30 cycles of 30 seconds at 94°C, 30 seconds at 60°C, and 45 seconds at 72°C, with an initial 9-minute denaturing step and a final 7-minute elongation step. Based on the sequences of human kNBC-1 and pNBC-1 (6, 7), four sets of primers were designed in the isoform-specific regions as well as the common region. The primer set for the kNBC-1–specific region was 5′-GCCCAGTAACCTTGGGGAGA-3′ (sense) and 5′-GCAGAAGTGAAAATACTGTGG-3′ (antisense), corresponding to nucleotides 175–84 and 248–268 in human kNBC-1 mRNA. The primer set for the pNBC-1–specific region was 5′-ATGGAGGATGAAGCTGTCCTG-3′ (sense) and 5′-CCGATGTAAATGGTATGGTGG-3′ (antisense), corresponding to nucleotides 118–138 and 192–212 in human pNBC-1 mRNA. One of the primer sets for the common region was 5′-CCTCAGCTCTTCACGGAACT-3′ (sense) and 5′-AGCATGACAGCCTGCTGTAG-3′ (antisense), corresponding to nucleotides 333–352 and 930–949 in kNBC-1 (or 433–452 and 1030–1049 in pNBC-1). Another set for the common region near the C terminus was 5′-TGGCTCCCATCTTGAAGTTTA-3′ (sense) and 5′-CAGCTACAAGTGCCAAGATCA-3′ (antisense), corresponding to nucleotides 2695–2716 and 2973–2994 in kNBC-1 (or 2795–2816 and 3073–3094 in pNBC-1). The amplified fragments by RT-PCR were subcloned into a TA vector (Invitrogen Corp., San Diego, California, USA), and sequenced.

Measurement of pHi. Cell-coated coverslips were incubated with HCO3–-free, HEPES-buffered Ringer’s solution containing 10 μmol/l bis(carboxyethyl)carboxyfluorescein/ acetoxymethylester (BCECF/AM) for 30–60 minutes at room temperature. The coverslip was then superfused with prewarmed (38°C) experimental solutions (Table 1) at approximately 5 ml/min in a chamber mounted on an inverted microscope (IMT-2; Olympus Optical Co., Tokyo, Japan), and pHi was measured with a microscopic fluorescence photometry system (OSP-10; Olympus Optical Co.) as described previously (13, 17). The intracellular dye was alternately excited at two wavelengths (440 and 490 nm), and emission was measured at a wavelength of 530 nm. Autofluorescence of cells was measured at the beginning of an experimental day, and these values were subtracted from the raw data. We used nigericin to acidify the cells as reported previously (4, 17), since the pilot experiments revealed that this method induced a more stable and predictable acidification than the NH4Cl-pulse technique in this cell line. However, in some experiments we also used NH4Cl to acidify the cells, and in this case 20 mmol/l NaCl in solution a was replaced with the equimolar amount of NH4Cl. The calibration curve for pHi was made according to the method of Thomas et al. (19). In brief, cells were exposed to HEPES-buffered solution containing 120 mmol/l K+ and 10 μmol/l nigericin, and solution pH was adjusted at the different levels (from 6.4 to 7.8) with 1 N NaOH. The results were expressed as mean values plus or minus SEM. Statistical analysis was determined using the unpaired t test or the Mann-Whitney test for single comparisons of groups. ANOVA with Bonferroni’s adjustment was used for multiple comparisons of data. A P value of less than 0.05 was considered statistically significant. BCECF/AM was obtained from Dojindo Laboratories (Kyushu, Japan), and 4, 4′-diisothiocyanatostilbene-2, 2′-disulphonic acid (DIDS), amiloride, valinomycin, and nigericin were from Sigma Chemical Co. (St. Louis, Missouri, USA). All the other chemicals were from Wako Pure Chemicals Industries (Osaka, Japan), unless otherwise specified.

Table 1

Composition of solutions

Construction of a hammerhead ribozyme against NBC-1. After the coding region of human valine tRNA was subcloned into a TA cloning vector pCR2.1 (Invitrogen Corp.), 9-bp deletion was introduced in the anticodon region to gain the unique restriction enzyme site of NruI. The oligonucleotide, 5′-AACATCCCTGATGAGTCCGTGAGGACGAAACTTGC-3′, and the complementary oligonucleotide were annealed together and subcloned into the NruI site of this plasmid to construct a NBC-1 mRNA–specific hammerhead ribozyme, RZ-NBC. The RZ sequence consisted of two flanking regions complementary to NBC-1 mRNA, targeting at the NBC-1 common region (GUA723 in kNBC-1 or GUA823 in pNBC-1), and a conserved catalytic sequence (20). The plasmid was then subcloned into pAdCMVlink lacking cytomegalovirus enhancer and promoter, linearized with EcoRI, and cotransfected to 293 cells together with adenoviral DNA digested with ClaI to construct the adenovirus vector carrying RZ-NBC. The adenovirus vector carrying the ribozyme against the microsomal triglycerides transfer protein (21) (RZ-MTP) was constructed as described above, except the oligonucleotides were designed to target the MTP gene (at GUC674). To examine the effects of RZ transfer into HLE cells, the cells were infected with 5 × 106 pfu/ml (8 moi) of adenovirus vector containing RZ-NBC, RZ-MTP, or LacZ gene for 2 hours in DMEM without FBS. After the cells were incubated in DMEM containing 20% FBS for 48 hours, pHi measurement and Western blot analysis were performed.

Western blot analysis. Western blot analysis was performed as described previously (17). In brief, HLE cells were lysed, and the membrane fraction was obtained by differential and discontinuous sucrose-gradient procedures as described (17). Protein concentrations were measured spectrophotometrically using a Bio-Rad Laboratories Inc. (Richmond, California, USA) protein assay kit. Equal amounts of protein (50 μg/lane) were dissolved in sample buffer, boiled for 5 minutes, separated by SDS-PAGE on 7% acrylamide minigels, and blotted onto a nitrocellulose membrane. After incubation in blocking buffer, the membrane was treated with the diluted (1:200) Ab against the NBC-1 C-terminal region and then with horseradish peroxidase-conjugated anti-rabbit IgG (Bio-Rad Laboratories Inc.) as the secondary Ab. The signal was detected by an ECL Plus system (Amersham International, Amersham, United Kingdom). To test for the specificity of anti–NBC-1 Ab’s, we transiently transfected ECV304 cells with either human kNBC-1 cDNA or human pNBC-1 cDNA, using nontransfected cells as a negative control as described previously (17). Two days after transfection, the membrane fraction was obtained, and Western blot analysis was performed as described above using the three different anti–NBC-1 Ab’s as the primary Ab.

Results

Specificity of anti–NBC-1 Ab’s. To test for the specificity of anti–NBC-1 Ab’s, we transiently expressed either kNBC-1 or pNBC-1 in ECV304 cells and performed Western blot analysis. As shown in Figure 1, the Ab against the NBC-1 C-terminal region recognized both kNBC-1 and pNBC-1 proteins expressed in these cells as reported previously (17). Figure 1 also shows that the Ab against the kNBC-1 N-terminal region recognized only the kNBC-1 protein, whereas the Ab against the pNBC-1 N-terminal region recognized only the pNBC-1 protein, confirming the specificity of these Ab’s.

Characterization of anti–NBC-1 Ab’s. Lane 1: nontransfected ECV304 cells. LFigure 1

Characterization of anti–NBC-1 Ab’s. Lane 1: nontransfected ECV304 cells. Lane 2: cells transfected with kNBC-1 cDNA. Lane 3: cells transfected with pNBC-1 cDNA. Western blot analysis was performed using the Ab’s against the NBC-1 C terminus (common), the kNBC-1 N terminus (k-specific), and the pNBC-1 N terminus (p-specific). A representative blot from three independent experiments is shown.

Localization of NBC-1 in the eye. To determine the localization of NBC-1 in the eye, we first used the Ab against the C-terminal region of NBC-1 (common Ab). Using the immunoperoxidase detection method, we identified an intense staining in the corneal endothelium, lens epithelium, and trabecular meshwork in the human eye (Figure 2a). The nonimmunized rabbit IgG gave no staining. Furthermore, the labeling by the anti–NBC-1 Ab was diminished in the presence of the antigen peptide, confirming the specificity of immunoreactions. With the immunofluorescence-detection method using confocal microscopy, a clear localization was evident in both nonpigmented and pigmented ciliary epithelia of the human eye (Figure 2b). In the rat eye, the labeling in the corneal endothelium appeared rather basolateral dominant, while the lens epithelium was more diffusely labeled (Figure 2c). Virtually identical results were obtained in the human eye. The other ocular tissues such as sclera, conjunctiva, corneal epithelium and stroma, lens fiber cells, ciliary muscle cells, and retina were not labeled.

Immunolocalization of NBC-1 in the eyes. (a) Peroxidase-antiperoxidase staiFigure 2

Immunolocalization of NBC-1 in the eyes. (a) Peroxidase-antiperoxidase staining of the human eye in the absence, Ag(-), and presence, Ag(+), of the antigen peptide. NBC-1 staining is brown. Co, cornea; Le, lens; Tm, trabecular meshwork; st, corneal stroma; en, corneal endothelium; cp, lens capsule; ep, lens epithelium; fb, lens fiber cells; sc, Schlemm’s canal. (b and c) Confocal laser microscopic image (confocal) and Nomarski-differential interference microscopic image (diff) of human (b) and rat (c) eyes. Red shows the localization of NBC-1 and green shows nuclei. Cb, ciliary body; pg, pigmented ciliary epithelium.

To determine which NBC-1 isoform is expressed in these ocular tissues, we next performed immunohistological analysis using the isoform’s specific Ab’s. In essence, we found that kNBC-1 and pNBC-1 are similarly distributed in the eye. In the human eye we detected the expression of both kNBC-1 and pNBC-1 in the corneal endothelium and trabecular meshwork using the immunoperoxidase-detection method (Figure 3a). The labeling by these Ab’s was diminished in the presence of corresponding antigen peptides. In the rat eye we also detected the expression of both NBC-1 isoforms in the ciliary epithelium, corneal endothelium, and lens epithelium using the immunofluorescence-detection method (Figure 3b). In the rat corneal endothelium and lens epithelium, the expression of kNBC-1 appeared rather dominant in the basolateral membranes (the stroma side in cornea and the capsule side in lens), whereas pNBC-1 seemed to be expressed more diffusely.

The expression of NBC-1 isoforms in the eyes. (a) Peroxidase-antiperoxidaseFigure 3

The expression of NBC-1 isoforms in the eyes. (a) Peroxidase-antiperoxidase staining of the human cornea and trabecular meshwork. (b) Confocal laser microscopic image of the rat ciliary body, cornea, and lens. Details as in Figure 2.

NBC-1 in HLE cells. These immunohistological findings suggest that NBC-1 represents a Na+-HCO3– cotransport activity reported previously in the corneal endothelium (13, 14, 22), ciliary epithelium (23, 24), and trabecular meshwork (25). However, the cotransport activity has not been detected in the mammalian lens epithelium (26). We therefore examined whether NBC-1 is expressed in HLE cells, the immortalized cells derived from the human lens epithelium (18). As shown in Figure 4, RT-PCR on the common NBC-1 region yielded amplified bands of the expected size (lane 1, 617 bp; lane 4, 300 bp). In addition, RT-PCR on the pNBC-1–specific region (lane 2, 95 bp) as well as the kNBC-1–specific region (lane 3; 94 bp) also yielded the expected bands. The sequences determined from each amplified cDNA fragments were completely identical to those of the corresponding portions of human kNBC-1 and pNBC-1.

The expression of NBC-1 mRNAs in HLE cells. RT-PCR analysis with (+) or witFigure 4

The expression of NBC-1 mRNAs in HLE cells. RT-PCR analysis with (+) or without (–) the reverse transcription step (RT). Lanes 1 and 4: the common regions in NBC-1. Lane 2: the pNBC-1–specific region. Lane 3: the kNBC-1–specific region.

To examine whether these cells have the transport activity compatible with NBC-1, pHi measurements were next performed. Figure 5a shows an acid-load experiment in the absence of HCO3–/CO2. After acidification by nigericin, cells did not show any pHi recovery in the absence of extracellular Na+. However, readdition of Na+ induced a prompt pHi recovery, and 1 mmol/l amiloride almost totally inhibited this process. The average rate of Na+-dependent pHi recovery was 1.42 ± 0.07 pH unit/min (n = 9) and 0.03 ± 0.004 pH unit/min (n = 7) in the absence and presence of amiloride, respectively. When 20 mmol/l NH4Cl pulse technique was used to acidify the cells instead of nigericin, the cells showed a very similar Na+-dependent pHi recovery (1.38 ± 0.12 pH unit/min, n = 5), which was again completely inhibited by 1 mmol/l amiloride. These results indicate that HLE cells recover from acid load mainly through the operation of a Na+/H+ exchanger in the absence of HCO3–/CO2. They also suggest that the problem of proton leak by residual nigericin would be minimal, if any, in our system.

(a) pHi recovery from acid in HLE cells. Results from two different experimFigure 5

(a) pHi recovery from acid in HLE cells. Results from two different experiments in the absence of HCO3–/CO2. Cells were acidified by nigericin in solution a (Table 1); then the perfusate was changed to solution b. pHi recovery was induced by solution a with or without 1 mmol/l amiloride (AML). (b) Three different experiments in the presence of HCO3–/CO2. Cells were acidified in solution c; then the perfusate was changed to solution d. Thereafter, pHi recovery was induced by solution c, solution c with 1 mmol/l AML, or solution c with 1 mmol/l AML and 0.3 mmol/l DIDS.

As shown in Figure 5b, pHi recovery from acid load in the presence of HCO3–/CO2 was also totally dependent on extracellular Na+. In this case, however, the Na+-dependent pHi recovery was only partially inhibited by amiloride. Thus the average rate of Na+-dependent pHi recovery was 0.94 ± 0.06 pH unit/min (n = 12) and 0.11 ± 0.01 pH unit/min (n = 11) in the absence and presence of amiloride, respectively, indicating that in addition to the Na+/H+ exchanger, another mechanism is operating in the presence of HCO3–/CO2. To test for the involvement of a Na+-HCO3– cotransporter in this process, we applied DIDS, a well-known inhibitor of this cotransporter. As also shown in Figure 5b, the joint application of amiloride and DIDS (0.3 mmol/l) completely inhibited the Na+-dependent pHi recovery (n = 5). When DIDS was applied to HLE cells incubated in standard HCO3– solution, steady-state pHi decreased from 7.46 ± 0.06 to 7.33 ± 0.05 after 3 minutes (P < 0.01; n = 6).

Although these results were consistent with the operation of a Na+-HCO3– cotransporter, a Na+-dependent Cl–/HCO3– exchanger could be involved also. To test for Cl–-dependency of the pHi recovery, cells were incubated in Cl–-free HCO3– solution for more than 30 minutes to deplete intracellular Cl–. These cells showed a very similar Na+-dependent pHi recovery in the presence of amiloride. Indeed, the rate of pHi recovery in the absence Cl– (0.11 ± 0.01 pH unit/min; n = 13) was not significantly different from that in standard HCO3– solution containing amiloride. Moreover, the pHi recovery was again completely inhibited by the joint application of amiloride and DIDS (n = 5), indicating that the DIDS-sensitive pHi recovery is independent of Cl–.

Since NBC-1 is known to be electrogenic (5–8), we next tested electrogenicity of the pHi recovery in Cl–-free HCO3– solution. After acidification by nigericin, cells were exposed to Na+-free, Cl–-free HCO3– solution containing a K+-ionophore, valinomycin (5 μmol/l). Subsequently, 72 mmol/l Na+-gluconate solution containing either low (2 mmol/l, solution h) or high (77 mmol/l, solution g) K+ was applied in the presence of both valinomycin and amiloride. Since NBC-1 is considered to carry a net negative charge by transporting more HCO3– than Na+, the less-negative membrane potentials, induced by valinomycin and a high-K+ solution, should be more favorable for HCO3– influx as shown previously in renal proximal tubular cells (17). As expected, the rate of pHi recovery was indeed faster in the high-K+ solution (0.09 ± 0.01 pH unit/min; n = 8) than that in the low-K+ solution (0.04 ± 0.01 pH unit/min; n = 8; P < 0.01), supporting the electrogenicity of this process. When 0.8 mmol/l quinine-HCl was used instead of valinomycin to inhibit the K+ conductance, the cells showed comparable pHi recovery in low-K+ (0.08 ± 0.01 pH unit/min; n = 6) and high-K+ solution (0.08 ± 0.01 pH unit/min; n = 6, NS), ruling out the involvement of K+-HCO3– cotransporter.

The results thus far strongly suggest that HLE cells have a Cl–-independent, electrogenic Na+-HCO3– cotransport activity compatible with NBC-1. To further validate this view, we examined the effects of a specific hammerhead ribozyme against NBC-1 (RZ-NBC), which was designed to target at the common region of human NBC-1 mRNA. Consistent with the highly efficient ability of hammerhead ribozyme to inhibit gene expression (20), adenovirus-mediated transfer of RZ-NBC into HLE cells quite effectively suppressed the expression of NBC-1 protein as estimated by Western blot analysis (Figure 6). In cells transfected with RZ-NBC, the pHi recovery from acid load in Cl–-free HCO3– solution containing amiloride was markedly slowed (Figure 7a), and the residual DIDS-sensitive Na+-HCO3– cotransport activity at 48 hours was only 20 ± 3% (n = 12) of the control value (Figure 7b). These effects of RZ-NBC were specific to NBC-1, since the Na+/H+ exchange activity assayed as amiloride-sensitive pHi recovery was unaffected by RZ-NBC (Figure 7c). To rule out any nonspecific effects that might be evoked by ribozyme transfer, we tested another hammerhead ribozyme (RZ-MTP) targeting against the microsomal triglycerides transfer protein that mediates apoB secretion from the liver (21). Unlike RZ-NBC, RZ-MTP had no effects on the expression of NBC-1 protein (Figure 6) or the Na+-HCO3– cotransport activity (Figure 7b).

Effects of RZ-NBC on the expression of NBC-1 protein in HLE cells estimatedFigure 6

Effects of RZ-NBC on the expression of NBC-1 protein in HLE cells estimated by Western blot analysis. The Ab against NBC-1 C terminus was used, and a representative blot from three independent experiments is shown. Lane 1: nontransfected control cells. Lane 2: cells transfected with adenovirus vector carrying LacZ. Lane 3: cells transfected with adenovirus vector carrying RZ-MTP. Lane 4: cells transfected with adenovirus vector carrying RZ-NBC.

Effects of RZ-NBC on the transport activities in HLE cells. (a) pHi recoverFigure 7

Effects of RZ-NBC on the transport activities in HLE cells. (a) pHi recovery from acid load in the absence of Cl–. Two different experiments from cells transfected with adenovirus vector carrying LacZ or adenovirus vector carrying RZ-NBC. (b) Na+-HCO3– cotransport activity determined as DIDS-sensitive pHi recovery in the Cl–-free HCO3– solution (solution e) containing 1 mmol/l amiloride. Cont, nontransfected control cells. Numbers of observations are 12 (Cont), 12 (LacZ), 10 (RZ-MTP), and 12 (RZ-NBC). *P < 0.001 compared with Cont. (c) Na+/H+ exchange activity determined as amiloride-sensitive pHi recovery in solution e. Numbers of observations are 12 (Cont), 10 (LacZ), 9 (RZ-MTP), and 10 (RZ-NBC). dpHi/dt, initial rate of pHi recovery.

Discussion

To determine the localization of NBC-1 in human and rat eyes, we used the anti–C-terminal Ab that recognizes both kNBC-1 and pNBC-1 or the anti–N-terminal Ab’s that can discriminate between these isoforms. These Ab’s were raised against highly specific regions of human NBC-1 and are unlikely to recognize other Na+-dependent and Na+-independent HCO3– transport molecules cloned so far (12, 27). Our results indicate that NBC-1 is present in the corneal endothelium, trabecular meshwork, ciliary epithelium, and lens epithelium. This localization potentially could explain the occurrence of ocular abnormalities in association with NBC-1 inactivation.

We have identified recently that the human corneal endothelial cells have the Na+-HCO3– cotransport activity and express mRNAs of both kNBC-1 and pNBC-1 (13). The present study further supports the view that NBC-1 represents the Na+-HCO3– cotransport activity in the corneal endothelium. Although we have detected the expression of both NBC-1 isoforms in the human and rat corneal endothelium, a recent study in the bovine corneal endothelium reported the expression of pNBC-1 only (14). We do not know the exact reason for the discrepant results, but species difference could be responsible. The corneal endothelium transports fluid, Na+, and HCO3– out of the corneal stroma into the aqueous humor, and this process is considered to be essential for the maintenance of corneal hydration and transparency (28). Therefore, the inactivation of NBC-1 may have a significant impact on the corneal homeostasis. In particular, the reduction of HCO3– efflux will increase the pH in the stroma, which may act in favor of Ca2+ deposition. Usually, the opacity of band keratopathy is caused by Ca2+ deposition into Bowman’s membrane. When associated with isolated pRTA, it is known to occur without any systemic Ca2+ abnormality (3).

The present study suggests that the Na+-HCO3– cotransport activity detected previously in human trabecular meshwork cells (25) could be due to NBC-1. Since the trabecular meshwork is the main site for aqueous outflow in the human eye (29), it is tempting to speculate that the inactivation of NBC-1 may somehow alter the properties of trabecular meshwork cells so as to increase the resistance of aqueous outflow. In particular, trabecular meshwork cells are known to have contractile properties, which may be influenced by Ca2+ influx through voltage-dependent L-type Ca2+ channels (30). The electrogenic nature of NBC-1 may, therefore, serve to stabilize the membrane potentials, which could be important for the regulation of Ca2+ influx and the contractility of these cells. However, the exact mechanism by which the trabecular meshwork alters its hydraulic resistance remains to be determined, and future studies will be required to clarify the role of NBC-1 in this process. The detection of NBC-1 in the ciliary body suggests that NBC-1 also may be involved in the production of aqueous humor. In fact, the presence of Na+-HCO3– cotransport activity in the ciliary epithelium has been suggested (23, 24). However, the contribution of other HCO3– transporters may be more important in the process of aqueous humor production (23, 31). On the other hand, we could not detect NBC-1 in the retina, where a Na+-HCO3– cotransport activity has been also reported (32). Probably, other transport molecules, such as NBC-2 (33), may be responsible for the cotransport activity in the retina.

Since previous studies failed to detect the Na+-HCO3– cotransport activity in mammalian lens epithelia (26), the immunohistological detection of NBC-1 in the lens epithelium in both human and rat eyes was quite surprising. However, our analysis on HLE cells, which retain the characteristics of the human lens epithelium (18), supported a view that NBC-1 is really expressed in the lens epithelium. Thus, RT-PCR analysis detected mRNAs of both kNBC-1 and pNBC-1, and Western blot analysis confirmed the expression of NBC-1 protein in these cells. In addition, functional analysis revealed the presence of Cl–-independent, electrogenic Na+-HCO3– cotransport activity that was sensitive to DIDS. Furthermore, the specific ribozyme against NBC-1 markedly suppressed this activity as well as the expression of NBC-1 protein. The physiological properties of NBC-1 thus characterized in HLE cells are very similar to those in the human corneal endothelial cells (13). In addition, since the application of DIDS decreased steady-state pHi, NBC-1 in the lens epithelium most likely functions as a bicarbonate uptake system into cells as also shown in the corneal endothelium (13).

The lens is an avascular tissue, and simple diffusion of nutrients into the lens seems to be insufficient to account for its metabolic consumption (34). Instead, the lens epithelium is considered to play a central role in the maintenance of lens homeostasis and integrity (35, 36). A recent study indeed demonstrated that the cultured lens epithelial cell layers and rabbit lenses in vitro actively transport fluid from their anterior to their posterior sides against a hydrostatic pressure (37). Based on the observed transport rates and the known presence of the water channel aquaporin-1 in lens epithelium (38), the active fluid transport by the lens epithelium was considered of great importance for lens homeostasis (37). Our present results, together with the existence of anterior side–positive, translenticular potential difference depending on both Na+ and HCO3– ions (39), strongly suggest that NBC-1 plays a major role in the active fluid transport by the lens epithelium. The presence of membrane-associated carbonic anhydrase in the lens epithelium also supports the importance of HCO3– transport in the lens (40). On the other hand, the diffuse cytosolic staining in the lens epithelium suggests that NBC-1 may also serve as a pH regulator of intracellular organelles. A recent study in the rat brain favors such multiple roles of NBC-1 (41). Transparency of the lens could be dependent on several physical properties, including the highly ordered protein structure and the homeostasis of intercellular and intracellular volume (35, 36). The inactivation of NBC-1 in the lens epithelium could somehow perturb these critical properties, which would ultimately result in cataract formation.

Figure 8 summarizes possible roles of NBC-1 in the ocular tissues. Previous studies have not detected major differences in the physiological properties of NBC-1 isoforms (5–8), and we observed very similar distribution patterns of kNBC-1 and pNBC-1 in the eye. It has been generally accepted that kNBC-1 functions as a bicarbonate exit pathway from renal proximal tubular cells in vivo with the stoichiometry of 1 Na+ to 3 HCO3– (42). Recent studies, however, suggested that this transport stoichiometry, one of the major determinants of transport direction of NBC-1, may not be fixed but may vary depending on the conditions of cells (43–45). Moreover, rat kNBC-1, when expressed in Xenopus oocytes, is reported to function with the 1 Na+ to 2 HCO3– stoichiometry (46, 47). Therefore, it would be not unreasonable to speculate that kNBC-1 can also operate as a bicarbonate uptake system into cells in other tissues such as the corneal endothelium. Nevertheless, we cannot exclude the possibility that these NBC-1 isoforms may have slightly different functional roles. In this regard, it is interesting to note that a patient having a nonsense mutation in the kNBC-1–specific region presented glaucoma but not band keratopathy or cataracts (48). Clearly, future studies will be required to understand the more precise roles of NBC-1 in the ocular tissues, and such knowledge will not only help improve the efficiency of corneal transplantation but also have significant impact on the therapeutic strategies for glaucoma and cataracts.

Possible roles of NBC-1 in the ocular tissues. Large arrows indicate the diFigure 8

Possible roles of NBC-1 in the ocular tissues. Large arrows indicate the direction of net fluid transport. In the cornea (a) and lens (b), NBC-1 likely contributes to the net fluid transport. In the trabecular meshwork cells (c), NBC-1 may affect the contractility of these cells via interaction with L-type Ca2+ channels. In the ciliary epithelium (d), the contribution of NBC-1 to the net fluid transport remains to be established.

Acknowledgments

This study was supported in part by grant 12671024 from the Ministry of Education, Science and Culture of Japan. Anti–NBC-1 Ab’s were supplied by Kumamoto Immunochemical Laboratory Co. (Kumamoto, Japan).

References
  1. Donckerwolcke, RA, Van Stekelenburg, GJ, Tiddens, HA. A case of bicarbonate-losing renal tubular acidosis with defective carboanhydrase activity. Arch Dis Child 1970. 45:769-773.
    View this article via: PubMed Google Scholar
  2. Winsnes, A, Monn, E, Stokke, O, Feyling, T. Congenital persistent proximal type renal tubular acidosis in two brothers. Acta Paediatr Scand 1979. 68:861-868.
    View this article via: PubMed Google Scholar
  3. Braverman, DE, Snyder, WE. A case report and review of band keratopathy. Metab Pediatr Syst Ophthalmol 1987. 70:39-41.
  4. Igarashi, T, et al. Mutations in SLC4A4 cause permanent isolated proximal renal tubular acidosis with ocular abnormalities. Nat Genet 1999. 23:264-266.
    View this article via: PubMed CrossRef Google Scholar
  5. Romero, MF, Hediger, MF, Boulpaep, EL, Boron, WF. Expression cloning and characterization of a renal electrogenic Na+/HCO3- cotransporter. Nature 1997. 387:409-413.
    View this article via: PubMed CrossRef Google Scholar
  6. Burnham, CE, Amlal, H, Wang, Z, Shull, GE, Soleimani, M. Cloning and functional expression of a human kidney Na+:HCO3- cotransporter. J Biol Chem 1997. 272:19111-19114.
    View this article via: PubMed CrossRef Google Scholar
  7. Abuladze, N, et al. Molecular cloning, chromosomal localization, tissue distribution, and functional expression of the human pancreatic sodium bicarbonate cotransporter. J Biol Chem 1998. 273:17689-17695.
    View this article via: PubMed CrossRef Google Scholar
  8. Choi, I, Romero, MF, Khandoudi, N, Bril, A, Boron, WF. Cloning and characterization of a human electrogenic Na+-HCO3- cotransporter isoform (hhNBC). Am J Physiol 1999. 276:C576-C584.
    View this article via: PubMed Google Scholar
  9. Abuladze, N, et al. Structural organization of the human NBC1 gene: kNBC1 is transcribed from an alternative promoter in intron 3. Gene 2000. 251:109-122.
    View this article via: PubMed CrossRef Google Scholar
  10. Alpern, RJ. Cell mechanisms of proximal tubule acidification. Physiol Rev 1990. 70:79-114.
    View this article via: PubMed Google Scholar
  11. Schmitt, BM, Biemesderfer, D, Romero, MF, Boulpaep, EL, Boron, WF. Immunolocalization of the electrogenic Na+-HCO3- cotransporter in mammalian and amphibian kidney. Am J Physiol 1999. 276:F27-F36.
    View this article via: PubMed Google Scholar
  12. Soleimani, M, Burnham, CE. Physiologic and molecular aspects of the Na+:HCO3- cotransporter in health and disease processes. Kidney Int 2000. 57:371-384.
    View this article via: PubMed CrossRef Google Scholar
  13. Usui, T, et al. Functional and molecular evidence for Na+-HCO3- cotransporter in human corneal endothelial cells. Pflügers Arch 1999. 438:458-462.
    View this article via: CrossRef Google Scholar
  14. Sun, XC, Bonanno, JA, Jelamski, S, Xie, Q. Expression and localization of Na+-HCO3- cotransporter in bovine corneal endothelium. Am J Physiol 2000. 279:C1648-C1655.
  15. Quigley, HA. Number of people with glaucoma worldwide. Br J Ophthalmol 1996. 80:389-393.
    View this article via: PubMed CrossRef Google Scholar
  16. Thylefors, B. Prevention of blindness-WHO’s mission for vision. World Health Forum 1998. 19:53-59.
    View this article via: PubMed Google Scholar
  17. Hara, C, et al. Intracellular pH regulatory mechanism in a human renal proximal cell line (HKC-8): evidence for Na+/H+ exchanger, Cl-/HCO3- exchanger, and Na+-HCO3- cotransporter. Pflügers Arch 2000. 440:713-720.
    View this article via: CrossRef Google Scholar
  18. Ibaraki, N, et al. Human lens epithelial cell line. Exp Eye Res 1998. 67:577-585.
    View this article via: PubMed CrossRef Google Scholar
  19. Thomas, JA, Buchsbaum, RN, Zimnick, A, Racker, F. Intracellular pH measurements in Ehrlich ascites tumor cells utilizing spectroscopic probes generated in situ. Biochemistry 1979. 18:2210-2218.
    View this article via: PubMed CrossRef Google Scholar
  20. Wang, JP, et al. Hammerhead ribozyme cleavage of apolipoprotein B mRNA generates a truncated protein. J Biol Chem 1999. 274:24161-24170.
    View this article via: PubMed CrossRef Google Scholar
  21. Chang, BHJ, et al. Liver-specific inactivation of the abetalipoproteinemia gene completely abrogates very low density lipoprotein/low density lipoprotein in a viable conditional knockout mouse. J Biol Chem 1999. 274:6051-6055.
    View this article via: PubMed CrossRef Google Scholar
  22. Jentsch, TJ, Keller, SK, Koch, M, Wiederholt, M. Evidence for coupled transport of bicarbonate and sodium in cultured bovine corneal endothelial cells. J Membr Biol 1984. 81:189-204.
    View this article via: PubMed CrossRef Google Scholar
  23. Carre, DA, Tang, CSR, Krupin, T, Civan, MM. Effect of bicarbonate on intracellular potential of rabbit ciliary epithelium. Curr Eye Res 1992. 11:609-624.
    View this article via: PubMed CrossRef Google Scholar
  24. Wolosin, JM, Bonanno, JM, Hanzel, D, Machen, TE. Bicarbonate transport mechanism in rabbit ciliary body epithelium. Exp Eye Res 1991. 52:397-407.
    View this article via: PubMed CrossRef Google Scholar
  25. Lepple-Wienhues, A, et al. Electrophysiological properties of cultured human trabecular meshwork cells. Exp Eye Res 1994. 59:305-311.
    View this article via: PubMed CrossRef Google Scholar
  26. Jentsch, TJ, Von der Haar, B, Keller, SK, Wiederholt, M. Response of the intracellular potentials of cultured bovine lens cells to ions and inhibitors. Exp Eye Res 1985. 41:131-144.
    View this article via: PubMed CrossRef Google Scholar
  27. Romero, MF, Boron, WF. Electrogenic Na+/HCO3- cotransporters: cloning and physiology. Annu Rev Physiol 1999. 61:699-723.
    View this article via: PubMed CrossRef Google Scholar
  28. Hodson, S, Miller, F. The bicarbonate ion pump in the endothelium which regulates the hydration of the rabbit cornea. J Physiol 1976. 263:563-577.
    View this article via: PubMed Google Scholar
  29. Bill, A. Blood circulation and fluid dynamics in the eye. Physiol Rev 1975. 55:383-417.
    View this article via: PubMed Google Scholar
  30. Steinhausen, K, Stumpff, F, Strauss, O, Thieme, H, Wiederholt, M. Influence of muscarinic agonists and tyrosine kinase inhibitors on L-type Ca2+ channels in human and bovine trabecular meshwork cells. Exp Eye Res 1999. 70:285-293.
    View this article via: PubMed CrossRef Google Scholar
  31. Helbig, H, Korbmacher, C, Kühner, D, Berweck, S, Wiederholt, M. Characterization of Cl-/HCO3- exchange in cultured bovine pigmented ciliary epithelium. Exp Eye Res 1988. 47:515-523.
    View this article via: PubMed CrossRef Google Scholar
  32. Hughes, BA, Adorante, JS, Miller, SS, Lin, H. Apical electrogenic NaHCO3 cotransport: a mechanism for HCO3 absorption across the retinal pigment epithelium. J Gen Physiol 1989. 94:125-150.
    View this article via: PubMed CrossRef Google Scholar
  33. Ishibashi, K, Sasaki, S, Marumo, F. Molecular cloning of a new sodium bicarbonate cotransporter cDNA from human retina. Biochem Biophys Res Commun 1989. 246:535-538.
    View this article via: PubMed CrossRef Google Scholar
  34. Harris, JE, Hauschild, JD, Nordquist, LT. Transport of glucose across the lens surface. Am J Ophthalmol 1955. 39:161-169.
    View this article via: PubMed Google Scholar
  35. Mathias, RT, Rae, JL. Transport properties of the lens. Am J Physiol 1985. 249:C181-C190.
    View this article via: PubMed Google Scholar
  36. Mathias, RT, Rae, JL, Baldo, GJ. Physiological properties of the normal lens. Physiol Rev 1997. 77:21-50.
    View this article via: PubMed Google Scholar
  37. Fischbarg, J, et al. Transport of fluid by lens epithelium. Am J Physiol 1999. 276:C548-C557.
    View this article via: PubMed Google Scholar
  38. Stamer, WD, Snyder, RW, Smith, BL, Agre, P, Regan, JW. Localization of aquaporin CHIP in the human eye: implications in the pathogenesis of glaucoma and other disorders of ocular fluid balance. Invest Ophthalmol Vis Sci 1994. 35:3867-3872.
    View this article via: PubMed Google Scholar
  39. Platsch, KD, Wiederholt, M. Effect of ion substitution and ouabain on short circuit current in the isolated human and rabbit lens. Exp Eye Res 1981. 32:615-625.
    View this article via: PubMed CrossRef Google Scholar
  40. Ridderstråle, Y, Wistrand, PJ, Brechue, WF. Membrane-associated CA activity in the eye of the CA II-deficient mouse. Invest Ophthalmol Vis Sci 1994. 35:2577-2584.
    View this article via: PubMed Google Scholar
  41. Schmitt, BM, et al. Na/HCO3 cotransporters in rat brain: expression in glia, neurons, and choroid plexus. J Neurosci 2000. 20:6839-6848.
    View this article via: PubMed Google Scholar
  42. Yoshitomi, K, Burckhardt, BC, Frömter, E. Rheogenic sodium-bicarbonate cotransport in the peritubular cell membrane of rat renal proximal tubule. Pflügers Arch 1985. 405:360-366.
    View this article via: CrossRef Google Scholar
  43. Seki, G, Coppola, S, Frömter, E. The Na+-HCO3- cotransporter operates with a coupling ratio of 2 HCO3- to 1 Na+ in isolated rabbit renal proximal tubule. Pflügers Arch 1993. 425:409-416.
    View this article via: CrossRef Google Scholar
  44. Seki, G, et al. On the mechanism of bicarbonate exit from renal proximal tubular cells. Kidney Int 1996. 49:1671-1677.
    View this article via: PubMed CrossRef Google Scholar
  45. Müller-Berger, S, Nesterov, VV, Frömter, E. Partial recovery of in vivo function by improved incubation conditions of isolated renal proximal tubule. II. Change of Na+-HCO3- cotransport stoichiometry and of response to acetazolamide. Pflügers Arch 1997. 434:383-391.
    View this article via: CrossRef Google Scholar
  46. Heyer, M, Müller-Berger, S, Romero, MF, Boron, WF, Frömter, E. Stoichiometry of the rat kidney Na+-HCO3- cotransporter expressed in Xenopus laevis oocytes. Pflügers Arch 1999. 438:322-329.
    View this article via: CrossRef Google Scholar
  47. Sciortino, CM, Romero, MF. Cation and voltage dependence of rat kidney electrogenic Na+-HCO3- cotransporter, rkNBC, expressed in oocytes. Am J Physiol 1999. 277:F611-F623.
    View this article via: PubMed Google Scholar
  48. Igarashi, T, et al. A novel nonsense mutation in the Na+/HCO3- cotransporter gene (SLC4A4) in a patient with permanent isolated proximal renal tubular acidosis and bilateral glaucoma. J Am Soc Nephrol 2001. 12:713-718.
    View this article via: PubMed Google Scholar
Version history
  • Version 1 (July 1, 2001): No description

Article tools

  • View PDF
  • Download citation information
  • Send a comment
  • Terms of use
  • Standard abbreviations
  • Need help? Email the journal

Metrics

  • Article usage
  • Citations to this article

Go to

  • Top
  • Abstract
  • Introduction
  • Methods
  • Results
  • Discussion
  • Acknowledgments
  • References
  • Version history
Advertisement
Advertisement

Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts